Seeking Alpha
  • Today - Thursday, November 27, 2014

  • 6:28 PM
     
    • Outbrain has filed notice confidentially with the Nasdaq seeking approval for a public listing of shares, according to the WSJ.
    • Sources indicate the integrated online advertising trailblazer seeks a valuation as high as $1B.
    • Outbrain's content recommendation product is considered one of the stronger Google Adsense alternatives for website publishers.
    | Comment!
  • Monday, November 24, 2014

  • 4:30 PM
    • Waltham, MA-based Histogenics (HSGX) is set for its IPO of 4.3M shares of common stock at $13 - 15.
    • The regenerative medicine company focuses on developing products in the musculoskeletal area. Its lead product is NeoCart, an autologous cartilage implant for the repair of cartilage damage in the knee. It is currently in Phase 3 development.
    • The first step in the process is the procurement of cartilage cells by a surgeon from the non-weight-bearing area of the patient's femur. After expanding, the cells are infused into the company's proprietary scaffold and then incubated in its Tissue Engineering Processor which mimics the conditions in the joint. When NeoCart is implanted, a bioadhesive is used to anchor it in place.
    • Enrollment in a 245-patient Phase 3 trial is underway. The primary efficacy endpoint is clinical superiority over the current standard of care, microfracture, at 12 months post implant.
    • Histogenics has yet generate meaningful revenue. Its net loss in 2013 was $25.7M and $23.7M in the first nine months of 2014.
    • ETFs: IBB, BIB, BIS (NYSEARCA:IPO)
    | Comment!
  • Friday, November 21, 2014

  • 11:46 AM
    • CB Pharma Acquisition Corp. (CNLMU) files for an IPO of 4M units priced at $10 per unit. Each unit consists of one share of common stock, one right to purchase 1/10 of a share of common stock on the consummation of an initial business combination and one warrant to purchase 1/2 of one share of common stock at a full-share price of $11.50.
    • The firm is a blank check company formed by Coronado Biosciences (CNDO +0.5%). It will seek business combinations via mergers, share exchanges, asset acquisitions, share purchases, recapitalizations or reorganizations.
    • It has 18 months from the consummation of this offering to complete its initial business combination (up to 21 months in certain circumstances) or it will liquidate the trust account, distribute the proceeds to shareholders and dissolve.
    • Per NASDAQ listing rules, the target business for the initial combination must have a fair market value equal to at least 80% of the value of the trust account.
    • ETFs: IBB, BIB, IRY, BIS, IXJ, DRGS (NYSEARCA:IPO)
    | Comment!
  • 11:42 AM
    • Peak Resorts (NASDAQ:SKIS) opens for trading with a small dip below its $9 IPO pricing.
    • The last trades for the ski operator went off at $8.81.
    • SEC Form S-1
    | Comment!
  • 8:24 AM
    • Shares of Habit Restaurants (NASDAQ:HABT) are off 5.9% in premarket trading on fairly active volume.
    • The fast-casual burger chain had one of the most explosive IPO debuts of the year yesterday when shares ripped a 120% gain to $39.54 off of a $18 pricing
    • SA contributor Don Dion noted in his IPO preview that the company's growth plans helped to justify a high valuation on HABT, although he needs to check back in to analyze if he's cozy at the +$39 level.
    • Previously: Sizzling IPO debut for Habit Restaurants
    | Comment!
  • Thursday, November 20, 2014

  • 11:42 AM
    • After pricing its 26.8M-share IPO at $7 (well below a $12.50-$14 range), European online retailer Cnova (NASDAQ:CNV) opened at $7.63 and is currently at $7.53, up 7.6%.
    • Cnova, based out of The Netherlands and controlled by French retail giant Casino, is currently worth $3.3B, or just ~1x trailing sales. Over the first nine months of 2014, the company had revenue of $3B (+20% Y/Y), and a net loss of $69.7M.
    • Prospectus, IPO preview
    | Comment!
  • 10:49 AM
     
    • The NY Post reports GoDaddy is looking to go public early next year, and seeking a $4.5B valuation.
    • The Web hosting/domain name services firm filed an S-1 in June, and has updated its filing three times since. In its latest update, GoDaddy disclosed it had revenue of $1.02B (+23% Y/Y) over the first 9 months of 2014, and a net loss of $116.5M. Bookings totaled $1.27B, and total customers stood at 12.5M (+11%) at the end of the period. trailing 12-month ARPU was $112 (+10%).
    • CFO Scott Wagner met with analysts last week, talking up his company's efforts to evolve into a broader provider of back-end services for Website owners.
    | Comment!
  • 8:53 AM
    • IPO Second Sight Medical Products (NASDAQ:EYES) is up 15% premarket on turnover of 133K shares. Shares are up over 150% from yesterday's debut price of $9. The company is yet another from serial entrepreneur Al Mann. His track record includes MannKind (NASDAQ:MNKD), Advanced Bionics and MiniMed.
    • Previously: Second Sight begins trading today
    | 1 Comment
  • Wednesday, November 19, 2014

  • 8:14 PM
    | 2 Comments
  • 10:39 AM
    | Comment!
  • 9:42 AM
    • Sylmar, CA-based Second Sight Medical Products (NASDAQ:EYES) debuts today via its IPO of 3.5M shares priced at $9.
    • The company develops visual prosthetics to restore some functional vision to blind patients. Its lead product is the Argus II System for the treatment of outer retinal degenerations such as retinitis pigmentosa. It is the only retinal prosthesis approved by the FDA and the first one approved anywhere in the world.
    • S-1
    • ETFs: IBB, BIB, BIS (NYSEARCA:IPO)
    | 2 Comments
  • Tuesday, November 18, 2014

  • 8:53 PM
    | 2 Comments
  • 11:01 AM
    • The opening trades for EHi Car Services (NYSE:EHIC) are a bit below the $12 mark where the IPO was priced earlier this morning.
    • Shares of the Chinese car rental service are down 3.2% with over 4M shares already being swapped.
    | Comment!
  • 9:21 AM
    • EHi Car Services (NYSE:EHIC) prices its $120M IPO at $12 which is on the low end of the $12-$14 range previously set.
    • Shares of the Chinese car rental firm are set to debut later today on the NYSE.
    • SEC Form F-1
    | Comment!
  • Monday, November 17, 2014

  • 9:18 AM
    • The $100M IPO for Peak Resorts (Pending:SKIS) is expected to launch this week.
    • The ski resort operator originally planned to go public back in 2011 before pulling back its IPO.
    • SEC Form S-1
    | Comment!
  • Friday, November 14, 2014

  • 1:46 PM
    • San Diego, CA-based Neothetics (NEOT) is set for its IPO of 4.3M shares of common stock at $13 - 15.
    • The clinical-stage specialty pharmaceutical firm develops therapeutics for the aesthetic market with an initial focus is on localized fat reduction and body contouring. Its lead product candidate is LIPO-202 (salmeterol xinafoate for injection) for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients (pot-belly). The company expects to conduct two Phase 3 trials in 1H 2015 and have top-line results by the end of 2015. If successful, it will file an NDA in 2H 2016.
    • 2013 Performance: Operating Expenses: $14.4M (+151.2%); Net Loss: ($15.0M) (-91.8%); Cash Burn: ($12.9M) (-74.3%).
    • 2014 Performance (9 mo.): Operating Expenses: $6.3M (-47.1%); Net Loss: ($7.9M) (+35.2%); Cash Burn: ($6.4M) (+40.2%).
    • ETFs: IBB, BIB, BIS (NYSEARCA:IPO)
    | 1 Comment
  • 1:20 PM
    • New York, NY-base S1 Biopharma (Pending:SXB) is set for its IPO of 2.75M shares of common stock at $12 - 14.
    • The clinical stage biopharmaceutical firm develops therapies for sexual dysfunction. Its lead product candidate is Lorexys, a fixed-dose combination therapy for the treatment of female hypoactive sexual desire disorder (HSDD), currently in Phase 2 clinicals. Its second product candidate is Orexa for the treatment of male HSDD. The company expects to initiate a Phase 2a study in Q2 2015 and a Phase 2b trial in 2016.
    • 2013 Performance: Operating Expenses: $1.8M (-131.1%); Net Loss: ($2.0M) (-144.0%); Cash Burn: ($719K) (-628.3%).
    • 1H 2014 Performance: Operating Expenses: $1.6M (+74.5%); Net Loss: ($1.8M) (-93.3%); Cash Burn: ($838K) (-148.9%).
    • ETFs: IBB, BIB, BIS (NYSEARCA:IPO)
    | Comment!
  • 10:34 AM
    • Virgin America (NASDAQ:VA) soars in its IPO debut.
    • Shares of the airliner are up over 22% from the $23 level where they were priced.
    • Virgin America trades with a $1B valuation which puts it well-above SkyWest and Republic Airways Holdings.
    • SEC Form S-1
    | 5 Comments
  • 7:48 AM
    | Comment!
  • 7:45 AM
    | Comment!
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector